Jain PharmaBiotech, May 2012, Pages: 1037
technologies, applications and geographical regions. Forecasts are made up to 2021. A major portion of the molecular diagnostic market can be attributed to advances in genomics and proteomics. Biochip and
Jain PharmaBiotech, May 2012, Pages: 633
known to have a neuroprotective effect. With the approval of new products and takeover of markets for obsolete symptomatic therapies, the neuroprotection market value will rise by the year 2016 when it
Life Science Intelligence, Inc., Dec 2009, Pages: 1763
acquires neurological signals from the brainand translates them into speech
- Percutaneously delivered implantable system to treat mitral valve regurgitation and improve congestive heart failure
Life Science Intelligence, Inc., July 2007
of tumor-specific nano-particles, adaptable to all solid tumors
Company 65 - Precise miniature robotic technology for spine, knee, orthopedic, and neurosurgery minimally invasive procedures
Global Industry Analysts, Inc., Oct 2010, Pages: 360
TomoTherapy in Strategic Alliance with PTW 107
Varian andBrainLAB Collaborate to Develop Novalis®Tx 107
XCounter Enters into Commercial Partnership with